PURPOSE: To examine the mortality risk associated with diabetes in the Mexico City Diabetes Study (MCDS) and the San Antonio Heart Study (SAHS). METHODS: Prospective cohorts conducted 1990-2007 in MCDS and 1979-2000 in SAHS. Mortality risk was examined using Cox proportional hazard models in 1402 non-Hispanic whites (NHW), 1907 U.S.-born Mexican-Americans (MA), 444 Mexican-born MA, and 2281 Mexico City residents (MCR) between the ages of 35-64. RESULTS: Age- and sex-adjusted mortality hazard ratios (HR) comparing U.S.-born MA, Mexican-born MA, and MCR to NHW were 1.09 (95% confidence interval [CI]: 0.86, 1.37), 1.23 (95% CI: 0.86, 1.76), and 0.97 (95% CI: 0.77, 1.23), respectively, in nondiabetic individuals; in contrast, mortality risk varied in diabetic individuals with respective HRs of 1.77 (95% CI: 1.20, 2.61), 1.08 (95% CI: 0.59, 1.97), and 2.27 (95% CI: 1.53, 3.35) (interaction p = .0003). Excluding Mexican-born MA and nondiabetic individuals, controlling for medication use, insulin use, fasting glucose levels, and duration of diabetes explained a significant proportion of the mortality differential (HRs relative to NHW were 1.31 [95% CI: 0.87, 1.98] in U.S.-born MA and 1.38 [95% CI: 0.89, 2.12] in MCR). CONCLUSIONS: This study provides evidence that diabetes is more lethal in U.S.-born MA and MCR than in NHW. Copyright Â
PURPOSE: To examine the mortality risk associated with diabetes in the Mexico City Diabetes Study (MCDS) and the San Antonio Heart Study (SAHS). METHODS: Prospective cohorts conducted 1990-2007 in MCDS and 1979-2000 in SAHS. Mortality risk was examined using Cox proportional hazard models in 1402 non-Hispanic whites (NHW), 1907 U.S.-born Mexican-Americans (MA), 444 Mexican-born MA, and 2281 Mexico City residents (MCR) between the ages of 35-64. RESULTS: Age- and sex-adjusted mortality hazard ratios (HR) comparing U.S.-born MA, Mexican-born MA, and MCR to NHW were 1.09 (95% confidence interval [CI]: 0.86, 1.37), 1.23 (95% CI: 0.86, 1.76), and 0.97 (95% CI: 0.77, 1.23), respectively, in nondiabetic individuals; in contrast, mortality risk varied in diabetic individuals with respective HRs of 1.77 (95% CI: 1.20, 2.61), 1.08 (95% CI: 0.59, 1.97), and 2.27 (95% CI: 1.53, 3.35) (interaction p = .0003). Excluding Mexican-born MA and nondiabetic individuals, controlling for medication use, insulin use, fasting glucose levels, and duration of diabetes explained a significant proportion of the mortality differential (HRs relative to NHW were 1.31 [95% CI: 0.87, 1.98] in U.S.-born MA and 1.38 [95% CI: 0.89, 2.12] in MCR). CONCLUSIONS: This study provides evidence that diabetes is more lethal in U.S.-born MA and MCR than in NHW. Copyright Â
Authors: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245
Authors: Kelly J Hunt; Ken Williams; Roy G Resendez; Helen P Hazuda; Steve M Haffner; Michael P Stern Journal: Diabetes Care Date: 2002-09 Impact factor: 19.112
Authors: Sarah Rosner Preis; Shih-Jen Hwang; Sean Coady; Michael J Pencina; Ralph B D'Agostino; Peter J Savage; Daniel Levy; Caroline S Fox Journal: Circulation Date: 2009-03-23 Impact factor: 29.690
Authors: Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto Journal: PLoS One Date: 2009-05-21 Impact factor: 3.240
Authors: Karol Estrada; Ingvild Aukrust; Lise Bjørkhaug; Noël P Burtt; Josep M Mercader; Humberto García-Ortiz; Alicia Huerta-Chagoya; Hortensia Moreno-Macías; Geoffrey Walford; Jason Flannick; Amy L Williams; María J Gómez-Vázquez; Juan C Fernandez-Lopez; Angélica Martínez-Hernández; Silvia Jiménez-Morales; Federico Centeno-Cruz; Elvia Mendoza-Caamal; Cristina Revilla-Monsalve; Sergio Islas-Andrade; Emilio J Córdova; Xavier Soberón; María E González-Villalpando; E Henderson; Lynne R Wilkens; Loic Le Marchand; Olimpia Arellano-Campos; Maria L Ordóñez-Sánchez; Maribel Rodríguez-Torres; Rosario Rodríguez-Guillén; Laura Riba; Laeya A Najmi; Suzanne B R Jacobs; Timothy Fennell; Stacey Gabriel; Pierre Fontanillas; Craig L Hanis; Donna M Lehman; Christopher P Jenkinson; Hanna E Abboud; Graeme I Bell; Maria L Cortes; Michael Boehnke; Clicerio González-Villalpando; Lorena Orozco; Christopher A Haiman; Teresa Tusié-Luna; Carlos A Aguilar-Salinas; David Altshuler; Pål R Njølstad; Jose C Florez; Daniel G MacArthur Journal: JAMA Date: 2014-06-11 Impact factor: 56.272
Authors: Steven K Rothschild; Molly A Martin; Susan M Swider; Carmen M Tumialán Lynas; Imke Janssen; Elizabeth F Avery; Lynda H Powell Journal: Am J Public Health Date: 2013-08-15 Impact factor: 9.308
Authors: S Lozano-Esparza; R López-Ridaura; E Ortiz-Panozo; C González-Villalpando; C Aguilar-Salinas; J E Hernández-Ávila; M Hernández-Ávila; M Lajous Journal: Diabetes Metab Date: 2019-09-13 Impact factor: 6.041